Donald Balfour, MD, FACP

home / authors / donald-balfour-md-facp

Articles

Site Logo
October 1st 2004

Treatment of the Adult and Transitional Patient

Gary Owens, MD Donald Balfour, MD, FACP S. Thomas Bigos, MD Jay Cohen, MD, FACE James Grua, MD, PhD, FACE Wynter Kipgen, MD Rajendra Ratnesar, MD Kenneth L. Schaecher, MD Mary Lee Vance, MD a

Site Logo
October 1st 2004

Prescription Benefit Design: Perspectives, Reimbursement Issues, and Future Trends

Gary Owens, MD Donald Balfour, MD, FACP Jay Cohen, MD, FACE Sanford Cohen, MD Michael Jacobs, RPh Michael Lease, MS, PharmD, FASCP Rajendra Ratnesar, MD Kenneth L. Schaecher, MD David E.

Site Logo
October 1st 2004

Clinical Presentation and Diagnosis: Growth Hormone Deficiency in Adults

Gary Owens, MD Donald Balfour, MD, FACP Beverly MK Biller, MD Jay Cohen, MD, FACE Michael Jacobs, RPh Michael Lease, MS, PharmD, FASCP Rajendra Ratnesar, MD Kenneth L. Schaecher, MD David

Latest Updated Articles

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Gene therapy, gene editing concept | image credit: vchalup - stock.adobe.com
Published: November 15th 2024 | Updated: November 18th 2024
Delandistrogene Moxeparvovec Fails to Meet Primary End Point in Phase 3 Study
Children with SMA are commonly affected by low bone mineral density | image credit: PT - stock.adobe.com
Published: November 13th 2024 | Updated: November 18th 2024
Low Bone Mineral Density Risk Increases With Age in SMA

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo